Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA approves longer-acting version of J&J's schizophrenia drug
FDA approves longer-acting version of J&J's schizophrenia drug
FDA approves longer-acting version of J&J's schizophrenia drug
Submitted by
admin
on May 19, 2015 - 10:35am
Source:
Yahoo/Reuters
News Tags:
FDA
JNJ
schizophrenia
Invega Trinza
Headline:
FDA approves longer-acting version of J&J's schizophrenia drug
Do Not Allow Advertisers to Use My Personal information
